Are you Dr. Li?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 14 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
6565 Fannin St
# M227
Houston, TX 77030Phone+1 713-441-3490Fax+1 713-793-1603
Summary
- Dr. Xiaoxian Li, MD is a board certified pathologist in Houston, Texas. He is currently licensed to practice medicine in Georgia and California. He is affiliated with Emory University Hospital.
Education & Training
- University of Texas M.D. Anderson Cancer CenterSelective Pathology, 2012 - 2013
- Methodist Hospital (Houston)Residency, Pathology-Anatomic and Clinical, 2007 - 2011
- Beijing Medical UniversityClass of 1997
Certifications & Licensure
- CA State Medical License 2011 - 2027
- GA State Medical License 2013 - 2027
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- Classification of fibroepithelial lesions of the breast in core needle biopsy with implications for further management.Emad A Rakha, Cecily Quinn, Wendy Raymond, Kimberly H Allison, Sunil S Badve
Modern Pathology. 2025-02-11 - The prevalence and clinical significance of residual occult breast cancer after neoadjuvant chemotherapy: reassessing surgical pathology in cases initially described a...Di Ai, Eliel N Arrey, Lauren M Postlewait, Yuan Gao, Xiaoxian Li
Histopathology. 2025-02-04 - Prioritizing cases from a multi-institutional cohort for a dataset of pathologist annotations.Victor Garcia, Emma Gardecki, Stephanie Jou, Xiaoxian Li, Kenneth R Shroyer
Journal of Pathology Informatics. 2025-01-01
Press Mentions
- Anatomic Pathology Selected AbstractsJanuary 21st, 2025
- Prognostic Value of Programmed Cell Death Ligand-1 Expression in Breast CancerDecember 4th, 2020
- Molecular Pathology Selected AbstractsMarch 22nd, 2024